Thrombosis and Haemostasis · 2005 · 11 citations · 9 references
MedicineHematologyPharmacotherapyHematopathologyHemostasisTransfusion MedicineCoagulation DisordersHemostatic DisordersPlatelet ActivationPlatelet FunctionThrombosisThrombotic DisordersAcquired Platelet Function DisordersBleedingFactor ViiaRecombinant Activated Factor ViiThrombosis Mechanisms
Essential thrombocythaemia is a chronic myeloproliferative disorder characterized by excessive proliferation of megakaryocytes with sustained increase of platelets count. Thromboembolic complications are major causes of morbidity and mortality. Severe bleeding is less frequent, and is usually seen in patients with very a high platelet count. The cause of bleeding seems to be an acquired platelet dysfunction. Activated recombinant FVII (rFVIIa) has shown to be haemostatically effective in bleeding associated with thrombocytopathy (6–8). Here we report a case, which suggests that rFVIIa might be a therapeutic option for uncontrolled bleeding in patients with essential thrombocythaemia. . . .
9
Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell
PJ Fialkow, GB Faguet, RJ Jacobson et al. · Blood · 1981 · 382 citations · Full text
Man‐Chiu Poon, Christine Demers, F Jobin et al. · Blood · 1999 · 196 citations
Medicine, Hematology, Surgery +12
Ton Lisman, Sultana Moschatsis, Jelle Adelmeijer et al. · Blood · 2003 · 105 citations · Full text
Medicine, Hematology, Hemostasis +14